Methods for in Situ Transcriptomics and Proteomics
Singular Genomics Systems, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 63/209,886, filed Jun 11, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,643,679 | Methods for in Situ Transcriptomics and Proteomics In force · High confidence UsedRemaining | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 11,891,656 | Methods for in Situ Transcriptomics and Proteomics In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 12,180,542 | In Situ Monitoring of Transcript and Protein Targets In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 12,286,666 | Methods for in Situ Transcriptomics and Proteomics In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 12,286,667 | In Situ Detection of Nucleic Acid Molecules In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 12,577,611 | Methods for in Situ Transcriptomics and Proteomics In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| US 11,492,662 | Methods for in Situ Transcriptomics and Proteomics In force · High confidence | Singular Genomics Systems, Inc. | In force | High confidence | ||
| Application 17/938,329 | Methods for in Situ Proteomics Pending Not granted | Singular Genomics Systems, Inc. | Pending | Not granted | ||
| Application 19/088,508 | Methods for Detecting Nucleic Acid Molecules in Cells Pending Not granted | Singular Genomics Systems, Inc. | Pending | Not granted | ||
| Application 19/345,390 | Encoding Methods for Multiplexed Detection of Targets in Cells Pending Not granted | Singular Genomics Systems, Inc. | Pending | Not granted | ||
| 1 more record in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
7 of these are in force and held by Singular Genomics Systems, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.